[Skip to Content]

Claim CME

Dermatology

How Dermatologists Can Learn and Contribute at the Leading Edge of the COVID-19 Global Pandemic

Educational Objective
To understand how dermatologists can learn and contribute to managing the COVID-19 pandemic

1 Credit CME

JAMA Dermatology

Published Online: April 30, 2020

Editorial

Article Information and Disclosures

Lauren M. Madigan, MD^1,2,3;

Robert G. Micheletti, MD^2,3,4;

Kanade Shinkai, MD, PhD^3,5,6

Author Affiliations

¹Department of Dermatology, University of Utah, Salt Lake City
²Section Coeditor, Clinical Images, JAMA Dermatology
³Society of Dermatology Hospitalists
⁴Departments of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia
⁵Department of Dermatology, University of California, San Francisco
⁶Editor, JAMA Dermatology

Read article on JAMA Network

Read Article Claim CME

In this issue of JAMA Dermatology, clinical cases and images of rashes in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are presented.¹^,2 Although these early observations are not comprehensive of all skin manifestations seen, our intention in publishing them is to help dermatologists recognize emerging patterns of rashes in patients with coronavirus disease 2019 (COVID-19). The reported prevalence of cutaneous signs in association with this pandemic is conflicting; one study reported a rash in only 0.2% of a cohort of Chinese patients,³ whereas the estimated prevalence in a cross-sectional Italian study was 20.4%.⁴ In the latter study, performed by dermatologists, the cutaneous manifestations were most commonly described as an erythematous rash; however, a range of additional morphologic features were observed, including generalized urticaria and vesicular eruptions. A predilection for the trunk was also noted.⁴ It may not be possible to determine the exact prevalence of skin findings in infected patients until serologic testing is more widely available, given that some individuals may lack the typical respiratory signs of COVID-19.⁵

Claim CME

Sign in to take quiz and track your certificates

Buy This Activity

Article Information

Corresponding author: Kanade Shinkai, 1701 Divisadero St, 3rd Floor, San Francisco, CA 94115 (kanade.shinkai@jamanetwork.org).

Published Online: April 30, 2020. doi:10.1001/jamadermatol.2020.1438

Conflict of Interest Disclosures: None reported.

Disclaimer: The views expressed herein are those of the authors and do not necessarily represent the perspectives of the Society of Dermatology Hospitalists.

References

Diaz-Guimaraens B , Dominguez-Santas M , Suarez-Valle A , et al. Petechial skin rash associated with severe acute respiratory syndrome coronavirus 2 infection. JAMA Dermatol. Published online April 30, 2020. doi:10.1001/jamadermatol.2020.1741 Google Scholar

Sanchez A , Sohier P , Benghanem S , et al. Digitate papulosquamous eruption associated with severe acute respiratory syndrome coronavirus 2 infection. JAMA Dermatol. Published online April 30, 2020. doi:10.1001/jamadermatol.2020.1704 Google Scholar

Guan WJ , Ni ZY , Hu Y , et al; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. Published online February 28, 2020. doi:10.1056/NEJMoa2002032 PubMed Google Scholar

Recalcati S . Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020. Published online March 26, 2020. doi:10.1111/jdv.16387 PubMed Google Scholar

Bai Y , Yao L , Wei T , et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406-1407. doi:10.1001/jama.2020.2565 PubMed Google Scholar Crossref

Wu X , Cai Y , Huang X , et al. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg Infect Dis. 2020;26(6). doi:10.3201/eid2606.200299 PubMed Google Scholar

Mazzotta F , Troccoli T . Acute acro-ischemia in the child at the time of COVID-19. Dermatologia Pediatrica. March 2020. Accessed April 23, 2020. https://img.beteve.cat/wp-content/uploads/2020/04/acroischemia-ENG.pdf

Wu P , Duan F , Luo C , et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. Published online March 31, 2020. doi:10.1001/jamaophthalmol.2020.1291 PubMed Google Scholar

AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;;
1.00 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;
1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and
1.00 CME points in the American Board of Surgery’s (ABS) Continuing Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.